Great 

Pfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%

A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug wa
Pfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论1

  • 推荐
  • 最新
empty
暂无评论